Literature DB >> 2003313

Scleroderma and central nervous system vasculitis.

R Pathak1, A J Gabor.   

Abstract

We describe a patient with scleroderma (CREST syndrome) and central nervous system vasculitis. While angiography demonstrated segmental symmetrical arterial narrowing characteristic of vasculitis, results of leptomeningeal biopsy were normal. There was no evidence of systemic vasculitis, renal failure, or malignant hypertension previously thought to be required to explain central nervous system dysfunction in patients with scleroderma. Signs and symptoms attributable to vasculitis were reversible with aggressive immunosuppressive therapy.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2003313     DOI: 10.1161/01.str.22.3.410

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  13 in total

1.  Neurosonological and cognitive screening for evaluation of systemic sclerosis patients.

Authors:  B R Sakr; R E Rabea; A M Aboulfotooh; N A Kishk
Journal:  Clin Rheumatol       Date:  2019-02-26       Impact factor: 2.980

2.  Non-atherosclerotic vascular disease in the young.

Authors:  Osvaldo Camilo; Larry B Goldstein
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

3.  Progressive systemic sclerosis with CNS vasculitis and cyclosporin A therapy.

Authors:  K Ishida; T Kamata; H Tsukagoshi; Y Tanizaki
Journal:  J Neurol Neurosurg Psychiatry       Date:  1993-06       Impact factor: 10.154

4.  Nervous system involvement in association with vasculitis and anticardiolipin antibodies in a patient with systemic sclerosis.

Authors:  A L Herrick; P Oogarah; T B Brammah; A J Freemont; M I Jayson
Journal:  Ann Rheum Dis       Date:  1994-05       Impact factor: 19.103

5.  Seizures in systemic sclerosis.

Authors:  Fernando Glasner Araújo; Tiago Nardi Amaral; Simone Appenzeller; Jozélio Freire de Carvalho
Journal:  Rheumatol Int       Date:  2012-12-29       Impact factor: 2.631

6.  Primary and secondary central nervous system vasculitis: clinical manifestations, laboratory findings, neuroimaging, and treatment analysis.

Authors:  Olga Vera-Lastra; Jesús Sepúlveda-Delgado; María del Pilar Cruz-Domínguez; Gabriela Medina; Moisés Casarrubias-Ramírez; Luis E Molina-Carrión; Luis F Pineda-Galindo; Arturo Olvera-Acevedo; Claudia Hernández-Gonzalez; Luis J Jara
Journal:  Clin Rheumatol       Date:  2014-11-27       Impact factor: 2.980

Review 7.  Cardiovascular disease in systemic sclerosis.

Authors:  Francesca Cannarile; Valentina Valentini; Giulia Mirabelli; Alessia Alunno; Riccardo Terenzi; Filippo Luccioli; Roberto Gerli; Elena Bartoloni
Journal:  Ann Transl Med       Date:  2015-01

8.  Vasculitis in systemic sclerosis.

Authors:  Lily Kao; Cornelia Weyand
Journal:  Int J Rheumatol       Date:  2010-09-30

9.  Systemic sclerosis associated with generalized vasculitis and hypopituitarism.

Authors:  John C Katsantonis; John Protopsaltis; Stelios Kokkoris; Paris Brestas; Kyriaki Aroni; Symeon Tournis; Gregory Giannoulis
Journal:  Rheumatol Int       Date:  2008-04-24       Impact factor: 2.631

10.  Brain MRI screening showing evidences of early central nervous system involvement in patients with systemic sclerosis.

Authors:  Reem Hamdy A Mohammed; Yousriah Y Sabry; Amr A Nasef
Journal:  Rheumatol Int       Date:  2010-01-13       Impact factor: 2.631

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.